GAITHERSBURG, Md.--(BUSINESS WIRE)--GenVec, Inc. (Nasdaq: GNVC) announced today the publication of pre-clinical research demonstrating that delivery of the atonal gene (math1) can re-establish sensory cells and inner ear function.
GAITHERSBURG, Md.--(BUSINESS WIRE)--GenVec, Inc. (Nasdaq: GNVC) announced today the publication of pre-clinical research demonstrating that delivery of the atonal gene (math1) can re-establish sensory cells and inner ear function.